knowledge -WSS

knowledge

author：Wikipedia 2025-10-08 16:06:38 - browse：75

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Medicare says breakthrough device reimbursement rule to come by summer

knowledge

WSS

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Medical mystery: When a cough is not just a cough

What should King Charles tell the public about his cancer?

A disappointing year of Humira biosimilars

Study: People of West African ancestry at greater risk of cardiac amyloidosis

H5N1 communication has been strictly for the birds

Wikipedia

knowledge

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

KalVista pill reduced swelling 'attacks' caused by genetic disease

Drug repurposing or repositioning? The language matters

After gene therapy, two congenitally deaf children hear for the first time

Moonlake's readout produced a cash windfall. Risks remain

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Psychedelics group wrestles with new pharma identity

Study: Adult vaccinations pay for themselves in societal benefits

Affirmative action in medical school literally saved lives

Readout LOUD podcast: brain research, obesity drug sales, Novartis

entertainment

Robert F. Kennedy is pitching centrism on health, even on abortion

Senators start work on Medicare physician payment reform

Study: Adult vaccinations pay for themselves in societal benefits

To avoid data mishandling cases, universities eye AI and other tools

Gilead might be held responsible for not developing a drug

Biogen Alzheimer’s drug launch off to slow start

focus

hotspot

knowledge

Wikipedia